OpenURL Connection Search

Select item for more details and to access through your institution.

Expanding the Arsenal of PtIV Anticancer Agents: Multi‐action PtIV Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional Group.
Published in:
Angewandte Chemie, 2019, v. 131, n. 50, p. 18386, doi. 10.1002/ange.201910014
By:
- Yempala, Thirumal;
- Babu, Tomer;
- Karmakar, Subhendu;
- Nemirovski, Alina;
- Ishan, Maisaloon;
- Gandin, Valentina;
- Gibson, Dan
Publication type:
Article
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death.
Published in:
Angewandte Chemie, 2023, v. 135, n. 42, p. 1, doi. 10.1002/ange.202310774
By:
- Sarkar, Amrita;
- Novohradsky, Vojtech;
- Maji, Moumita;
- Babu, Tomer;
- Markova, Lenka;
- Kostrhunova, Hana;
- Kasparkova, Jana;
- Gandin, Valentina;
- Brabec, Viktor;
- Gibson, Dan
Publication type:
Article
Oral Anticancer Heterobimetallic PtIV−AuI Complexes Show High In Vivo Activity and Low Toxicity.
Published in:
Angewandte Chemie, 2023, v. 135, n. 10, p. 1, doi. 10.1002/ange.202217233
By:
- Babu, Tomer;
- Ghareeb, Hiba;
- Basu, Uttara;
- Schueffl, Hemma;
- Theiner, Sarah;
- Heffeter, Petra;
- Koellensperger, Gunda;
- Metanis, Norman;
- Gandin, Valentina;
- Ott, Ingo;
- Schmidt, Claudia;
- Gibson, Dan
Publication type:
Article
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death.
Published in:
Angewandte Chemie International Edition, 2023, v. 62, n. 42, p. 1, doi. 10.1002/anie.202310774
By:
- Sarkar, Amrita;
- Novohradsky, Vojtech;
- Maji, Moumita;
- Babu, Tomer;
- Markova, Lenka;
- Kostrhunova, Hana;
- Kasparkova, Jana;
- Gandin, Valentina;
- Brabec, Viktor;
- Gibson, Dan
Publication type:
Article
Oral Anticancer Heterobimetallic PtIV−AuI Complexes Show High In Vivo Activity and Low Toxicity.
Published in:
Angewandte Chemie International Edition, 2023, v. 62, n. 10, p. 1, doi. 10.1002/anie.202217233
By:
- Babu, Tomer;
- Ghareeb, Hiba;
- Basu, Uttara;
- Schueffl, Hemma;
- Theiner, Sarah;
- Heffeter, Petra;
- Koellensperger, Gunda;
- Metanis, Norman;
- Gandin, Valentina;
- Ott, Ingo;
- Schmidt, Claudia;
- Gibson, Dan
Publication type:
Article
Expanding the Arsenal of PtIV Anticancer Agents: Multi‐action PtIV Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional Group.
Published in:
Angewandte Chemie International Edition, 2019, v. 58, n. 50, p. 18218, doi. 10.1002/anie.201910014
By:
- Yempala, Thirumal;
- Babu, Tomer;
- Karmakar, Subhendu;
- Nemirovski, Alina;
- Ishan, Maisaloon;
- Gandin, Valentina;
- Gibson, Dan
Publication type:
Article

Found: 6

Expanding the Arsenal of Pt<sup>IV</sup> Anticancer Agents: Multi‐action Pt<sup>IV</sup> Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional Group.

Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death.

Oral Anticancer Heterobimetallic Pt<sup>IV</sup>−Au<sup>I</sup> Complexes Show High In Vivo Activity and Low Toxicity.

Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death.

Oral Anticancer Heterobimetallic Pt<sup>IV</sup>−Au<sup>I</sup> Complexes Show High In Vivo Activity and Low Toxicity.

Expanding the Arsenal of Pt<sup>IV</sup> Anticancer Agents: Multi‐action Pt<sup>IV</sup> Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional Group.